The Covid-19 pandemic had a strong impact on clinical trials at a global scale, disrupting clinical trials from April 2020.
According to a recent report from Global Data, slow enrollment is the main cause accounting for 49% of disrupted clinical trials.
The second is enrollment suspension (35%) and the third is delayed initiation (16%).
Our web application CT-SCOUT™ aims to accelerate the detection of potentially eligible patients for clinical trials at site in order to increase recruitment and indeed to reduce delays in clinical trials.
Click here to request a demo: https://www.ctma.fr/contact-us/